C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study
Authors
Discussion
Loading...
Member takes
Implication
Copeptin may refine post-AMI heart failure risk stratification beyond natriuretic peptides; supports prospective validation before clinical adoption.
Key Points
Key points are not available for this paper at this time.
Cite This Study
Voors et al. (2009) studied this question.